RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours

2005 ◽  
Vol 206 (4) ◽  
pp. 409-416 ◽  
Author(s):  
S Pizzi ◽  
C Azzoni ◽  
L Bottarelli ◽  
N Campanini ◽  
T D'Adda ◽  
...  
Keyword(s):  
Loss Of Heterozygosity ◽  
Promoter Methylation ◽  
Endocrine Tumours

scholarly journals Loss of CDX1 expression in colorectal carcinoma: Promoter methylation, mutation, and loss of heterozygosity analyses of 37 cell lines

2004 ◽  
Vol 101 (2) ◽  
pp. 574-579 ◽  
Author(s):  
N. A. C. S. Wong ◽  
M. P. Britton ◽  
G. S. Choi ◽  
T. K. Stanton ◽  
D. C. Bicknell ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Loss Of Heterozygosity ◽  
Cell Lines ◽  
Promoter Methylation

Correlation among loss of heterozygosity, promoter methylation and protein expression of MLH1 in larynx cancer

2004 ◽  
Author(s):  
Robert Smigiel ◽  
Agnieszka Stembalska-Kozlowska ◽  
Farhad Mirghomizadeh ◽  
Tomasz Krecicki ◽  
Tomasz Zatonski ◽  
...  
Keyword(s):  
Protein Expression ◽  
Loss Of Heterozygosity ◽  
Promoter Methylation ◽  
Larynx Cancer

scholarly journals Imprinted tumor suppressor genesARHI andPEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation

Cancer ◽  
2008 ◽  
Vol 112 (7) ◽  
pp. 1489-1502 ◽  
Author(s):  
Weiwei Feng ◽  
Rebecca T. Marquez ◽  
Zhen Lu ◽  
Jinsong Liu ◽  
Karen H. Lu ◽  
...  
Keyword(s):  
Tumor Suppressor ◽  
Loss Of Heterozygosity ◽  
Promoter Methylation ◽  
Ovarian Cancers

Lack of TNFα mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation

2008 ◽  
Vol 45 (1) ◽  
pp. 152-159 ◽  
Author(s):  
Judith N. Kloth ◽  
Arko Gorter ◽  
Natalja ter Haar ◽  
Willem E. Corver ◽  
Ekaterina S. Jordanova ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Mrna Expression ◽  
Loss Of Heterozygosity ◽  
Promoter Methylation ◽  
Inactivating Mutations

Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer

Lung Cancer ◽  
2012 ◽  
Vol 77 (2) ◽  
pp. 272-276 ◽  
Author(s):  
Pirooz Poursoltan ◽  
Nicola Currey ◽  
Laurent Pangon ◽  
Christa van Kralingen ◽  
Christina I. Selinger ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Loss Of Heterozygosity ◽  
Cell Lung Cancer ◽  
Promoter Methylation ◽  
Small Cell ◽  
Cancer Gene ◽  
Small Cell Lung

scholarly journals Loss of Heterozygosity and Promoter Methylation, but not Mutation, May Underlie Loss of TFF1 in Gastric Carcinoma

2002 ◽  
Vol 82 (10) ◽  
pp. 1319-1326 ◽  
Author(s):  
Ralph Carvalho ◽  
Tuncay Kayademir ◽  
Paula Soares ◽  
Paulo Canedo ◽  
Sónia Sousa ◽  
...  
Keyword(s):  
Gastric Carcinoma ◽  
Loss Of Heterozygosity ◽  
Promoter Methylation

scholarly journals PTEN mutation, loss of heterozygosity, promoter methylation and expression in colorectal carcinoma: Two hits on the gene?

2014 ◽  
Vol 31 (5) ◽  
pp. 2236-2244 ◽  
Author(s):  
MAJA HÜHNS ◽  
TAREQ SALEM ◽  
BJÖRN SCHNEIDER ◽  
MATHIAS KROHN ◽  
MICHAEL LINNEBACHER ◽  
...  
Keyword(s):  
Colorectal Carcinoma ◽  
Loss Of Heterozygosity ◽  
Promoter Methylation ◽  
Pten Mutation

Abstract #60: PTEN Promoter Methylation is Specifically Detected in Differentiated Thyroid Cancers

2003 ◽  
Vol 9 ◽  
pp. 23-24
Author(s):  
Francisco Alvarez ◽  
Helena Bussaglia ◽  
Monica Vilar ◽  
Juan Ybarra ◽  
Alberto de Leiva ◽  
...  
Keyword(s):  
Promoter Methylation ◽  
Thyroid Cancers ◽  
Differentiated Thyroid Cancers

GPER is inactivated by promoter methylation and potentially functions as a tumor suppressor in breast cancer

2014 ◽  
Vol 74 (S 01) ◽  
Author(s):  
C Weißenborn ◽  
T Ignatov ◽  
SD Costa ◽  
AC Zenclussen ◽  
A Ignatov
Keyword(s):  
Breast Cancer ◽  
Tumor Suppressor ◽  
Promoter Methylation
Sign in / Sign up

Export Citation Format

Share Document